🦠

Understanding Viral Hepatitis A to E

May 3, 2025

Epidemiology and Prevention of Viral Hepatitis A to E

Overview of Hepatitis Viruses

  • Types: Hepatitis A, B, C, D, E
  • Transmission modes:
    • Fecal-oral (Hepatitis A, E)
    • Blood/body fluids (Hepatitis B, C, D)
  • Chronic infection possibility:
    • Yes: B, C, D
    • No: A, E

Historical Perspective

  • Source of virus varies: feces, blood, blood-derived body fluids
  • Route of transmission: fecal-oral, percutaneous, permucosal
  • Prevention includes immunization, screening, and behavior modification

Hepatitis A Virus (HAV)

Characteristics

  • Incubation period: Average 21 days (14-50 days range)
  • Symptoms: Jaundice varies by age
    • <6 yrs: <10%
    • 6-14 yrs: 40-50%
    • 14 yrs: 70-80%

  • Complications: Fulminant, cholestatic, and relapsing hepatitis
  • Chronic Sequelae: None

Transmission

  • Main source: Stool
  • Methods:
    • Personal contact (household, child care, sexual)
    • Contaminated food/water (food handlers, shellfish)
    • Rare blood exposure (drug use, transfusion)

Diagnosis and Prevention

  • Diagnosis through detection of HAV-IgM in serum
  • Prevention:
    • Sanitation improvement
    • Vaccination for travelers, high-risk groups
    • Post-exposure prophylaxis with vaccine or IG

Hepatitis B Virus (HBV)

Characteristics

  • DNA virus, part of Hepadnaviridae family
  • Contains 4 genes: S, C, X, P
  • Incubation period: Average 60-90 days (45-180 days range)
  • Chronic infection varies by age at exposure

Transmission

  • High-risk fluids: blood, semen, saliva
  • Modes: Sexual, parenteral, perinatal

Diagnosis and Treatment

  • Serological tests: HBsAg, HBsAb, Anti-HBc, HBeAg
  • Treatment for chronic HBV: Interferon, nucleos(t)ide analogs
  • Prevention through vaccination and immunoglobulin

Hepatitis D (Delta) Virus (HDV)

Characteristics

  • Coinfection and superinfection scenarios
  • High risk of chronic infection with superinfection

Transmission and Prevention

  • Percutaneous and permucosal exposure
  • Prevention involves education on risk reduction

Treatment

  • Interferon alpha for 48 to 72 weeks
  • Nucleos(t)ide analogs ineffective

Hepatitis C Virus (HCV)

Characteristics

  • RNA virus, Flaviviridae family
  • Incubation period: 6-7 weeks (2-26 weeks range)
  • High rate of chronic hepatitis and persistence

Transmission

  • Modes: Percutaneous, sexual, perinatal
  • Risk factors include drug use, tattoos, and transfusions

Diagnosis and Treatment

  • HCV antibody and RNA detection
  • Treatment: Direct-acting antivirals (DAAs)
  • Prevention through screening and behavior modification

Hepatitis E Virus (HEV)

Characteristics

  • RNA virus, Hepeviridae family
  • Incubation period: 40 days (15-60 days range)
  • High fatality in pregnant women

Transmission and Prevention

  • Self-limited acute infection
  • Avoid unsafe water and food in endemic areas
  • ?Vaccine?